And one release of our typically half cocked paper work would probably reveal why.
That and what health Minister wants to get involved in meddling with approving health products? It's not like our product is life and death.
Clearly we have neglected the Aus market for years (and the good news stories and goodwill that would have gone with it) - so why start now when the story looks more like a Greek tragedy than a bright bio future for Australian start ups. More likely an Asian success story now.
And one release of our typically half cocked paper work would...
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
-0.300(1.64%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.29 | $18.30 | $17.65 | $181.7K | 10.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $17.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.00 | 499 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |